What is Alamar Biosciences 's investing cash flow?

Alamar Biosciences (ALMR) reported investing cash flow of -$778K in Q1 2026.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Alamar Biosciences ALMR Investing Cash Flow

Investing Cash Flow at other companies

FBR

Franklin BSP Realty TrustFBRT

-$246.11M-186%

PayPal Holdings, Inc.PYPL

-$2.1B+42.3%

SiTime CorporationSITM

$483.68M+1,236%

Brown & BrownBRO

-$38M+51.9%

Granite Point Mortgage TrustGPMT

$173.63M+117%

CignaCI

-$637M-153%

Other financials

Income statement

See full

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

See full

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

See full

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

See full

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

See full

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alamar Biosciences 's investing cash flow?: Alamar Biosciences (ALMR) reported investing cash flow of -$778K in Q1 2026.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.